Global Targeting DNA Repair Drugs Market Growth 2026-2032
The global Targeting DNA Repair Drugs market size is predicted to grow from US$ 874 million in 2025 to US$ 2452 million in 2032; it is expected to grow at a CAGR of 16.2% from 2026 to 2032.
DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations. This report mainly focuses on targeting DNA repair drugs market.
In 2022, Asia-Pacific holds highest share in targeting DNA repair drugs .
LP Information, Inc. (LPI) ' newest research report, the “Targeting DNA Repair Drugs Industry Forecast” looks at past sales and reviews total world Targeting DNA Repair Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeting DNA Repair Drugs sales for 2026 through 2032. With Targeting DNA Repair Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeting DNA Repair Drugs industry.
This Insight Report provides a comprehensive analysis of the global Targeting DNA Repair Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeting DNA Repair Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeting DNA Repair Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeting DNA Repair Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeting DNA Repair Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeting DNA Repair Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations. This report mainly focuses on targeting DNA repair drugs market.
In 2022, Asia-Pacific holds highest share in targeting DNA repair drugs .
LP Information, Inc. (LPI) ' newest research report, the “Targeting DNA Repair Drugs Industry Forecast” looks at past sales and reviews total world Targeting DNA Repair Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeting DNA Repair Drugs sales for 2026 through 2032. With Targeting DNA Repair Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeting DNA Repair Drugs industry.
This Insight Report provides a comprehensive analysis of the global Targeting DNA Repair Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeting DNA Repair Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeting DNA Repair Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeting DNA Repair Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeting DNA Repair Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeting DNA Repair Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Olaparib
- Rucaparib
- Niraparib
- Talazoparib
- Others
- Ovarian Cancer
- Fallopian Tube Cancer
- Peritoneal Cancer
- Breast Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Onxeo
- FoRx Therapeutics
- Artios Pharma Limited
- Merck KGaA
- Breakpoint Therapeutics
- Luciole Pharmaceuticals
- AstraZeneca
- AbbVie
- Johnson & Johnson
- Pfizer
- ClovisOncology
- GlaxoSmithKline
- What is the 10-year outlook for the global Targeting DNA Repair Drugs market?
- What factors are driving Targeting DNA Repair Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Targeting DNA Repair Drugs market opportunities vary by end market size?
- How does Targeting DNA Repair Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeting DNA Repair Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Targeting DNA Repair Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Targeting DNA Repair Drugs by Country/Region, 2021, 2025 & 2032
2.2 Targeting DNA Repair Drugs Segment by Type
2.2.1 Olaparib
2.2.2 Rucaparib
2.2.3 Niraparib
2.2.4 Talazoparib
2.2.5 Others
2.2.6 Targeting DNA Repair Drugs Sales by Type
2.2.6.1 Global Targeting DNA Repair Drugs Sales Market Share by Type (2021-2026)
2.2.6.2 Global Targeting DNA Repair Drugs Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Targeting DNA Repair Drugs Sale Price by Type (2021-2026)
2.3 Targeting DNA Repair Drugs Segment by Application
2.3.1 Ovarian Cancer
2.3.2 Fallopian Tube Cancer
2.3.3 Peritoneal Cancer
2.3.4 Breast Cancer
2.3.5 Others
2.3.6 Targeting DNA Repair Drugs Sales by Application
2.3.6.1 Global Targeting DNA Repair Drugs Sale Market Share by Application (2021-2026)
2.3.6.2 Global Targeting DNA Repair Drugs Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Targeting DNA Repair Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Targeting DNA Repair Drugs Breakdown Data by Company
3.1.1 Global Targeting DNA Repair Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Targeting DNA Repair Drugs Sales Market Share by Company (2021-2026)
3.2 Global Targeting DNA Repair Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Targeting DNA Repair Drugs Revenue by Company (2021-2026)
3.2.2 Global Targeting DNA Repair Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Targeting DNA Repair Drugs Sale Price by Company
3.4 Key Manufacturers Targeting DNA Repair Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Targeting DNA Repair Drugs Product Location Distribution
3.4.2 Players Targeting DNA Repair Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TARGETING DNA REPAIR DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Targeting DNA Repair Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Targeting DNA Repair Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Targeting DNA Repair Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Targeting DNA Repair Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Targeting DNA Repair Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Targeting DNA Repair Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Targeting DNA Repair Drugs Sales Growth
4.4 APAC Targeting DNA Repair Drugs Sales Growth
4.5 Europe Targeting DNA Repair Drugs Sales Growth
4.6 Middle East & Africa Targeting DNA Repair Drugs Sales Growth
5 AMERICAS
5.1 Americas Targeting DNA Repair Drugs Sales by Country
5.1.1 Americas Targeting DNA Repair Drugs Sales by Country (2021-2026)
5.1.2 Americas Targeting DNA Repair Drugs Revenue by Country (2021-2026)
5.2 Americas Targeting DNA Repair Drugs Sales by Type (2021-2026)
5.3 Americas Targeting DNA Repair Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeting DNA Repair Drugs Sales by Region
6.1.1 APAC Targeting DNA Repair Drugs Sales by Region (2021-2026)
6.1.2 APAC Targeting DNA Repair Drugs Revenue by Region (2021-2026)
6.2 APAC Targeting DNA Repair Drugs Sales by Type (2021-2026)
6.3 APAC Targeting DNA Repair Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Targeting DNA Repair Drugs by Country
7.1.1 Europe Targeting DNA Repair Drugs Sales by Country (2021-2026)
7.1.2 Europe Targeting DNA Repair Drugs Revenue by Country (2021-2026)
7.2 Europe Targeting DNA Repair Drugs Sales by Type (2021-2026)
7.3 Europe Targeting DNA Repair Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeting DNA Repair Drugs by Country
8.1.1 Middle East & Africa Targeting DNA Repair Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Targeting DNA Repair Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Targeting DNA Repair Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Targeting DNA Repair Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Targeting DNA Repair Drugs
10.3 Manufacturing Process Analysis of Targeting DNA Repair Drugs
10.4 Industry Chain Structure of Targeting DNA Repair Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Targeting DNA Repair Drugs Distributors
11.3 Targeting DNA Repair Drugs Customer
12 WORLD FORECAST REVIEW FOR TARGETING DNA REPAIR DRUGS BY GEOGRAPHIC REGION
12.1 Global Targeting DNA Repair Drugs Market Size Forecast by Region
12.1.1 Global Targeting DNA Repair Drugs Forecast by Region (2027-2032)
12.1.2 Global Targeting DNA Repair Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Targeting DNA Repair Drugs Forecast by Type (2027-2032)
12.7 Global Targeting DNA Repair Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Onxeo
13.1.1 Onxeo Company Information
13.1.2 Onxeo Targeting DNA Repair Drugs Product Portfolios and Specifications
13.1.3 Onxeo Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Onxeo Main Business Overview
13.1.5 Onxeo Latest Developments
13.2 FoRx Therapeutics
13.2.1 FoRx Therapeutics Company Information
13.2.2 FoRx Therapeutics Targeting DNA Repair Drugs Product Portfolios and Specifications
13.2.3 FoRx Therapeutics Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 FoRx Therapeutics Main Business Overview
13.2.5 FoRx Therapeutics Latest Developments
13.3 Artios Pharma Limited
13.3.1 Artios Pharma Limited Company Information
13.3.2 Artios Pharma Limited Targeting DNA Repair Drugs Product Portfolios and Specifications
13.3.3 Artios Pharma Limited Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Artios Pharma Limited Main Business Overview
13.3.5 Artios Pharma Limited Latest Developments
13.4 Merck KGaA
13.4.1 Merck KGaA Company Information
13.4.2 Merck KGaA Targeting DNA Repair Drugs Product Portfolios and Specifications
13.4.3 Merck KGaA Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck KGaA Main Business Overview
13.4.5 Merck KGaA Latest Developments
13.5 Breakpoint Therapeutics
13.5.1 Breakpoint Therapeutics Company Information
13.5.2 Breakpoint Therapeutics Targeting DNA Repair Drugs Product Portfolios and Specifications
13.5.3 Breakpoint Therapeutics Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Breakpoint Therapeutics Main Business Overview
13.5.5 Breakpoint Therapeutics Latest Developments
13.6 Luciole Pharmaceuticals
13.6.1 Luciole Pharmaceuticals Company Information
13.6.2 Luciole Pharmaceuticals Targeting DNA Repair Drugs Product Portfolios and Specifications
13.6.3 Luciole Pharmaceuticals Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Luciole Pharmaceuticals Main Business Overview
13.6.5 Luciole Pharmaceuticals Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Targeting DNA Repair Drugs Product Portfolios and Specifications
13.7.3 AstraZeneca Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 AbbVie
13.8.1 AbbVie Company Information
13.8.2 AbbVie Targeting DNA Repair Drugs Product Portfolios and Specifications
13.8.3 AbbVie Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 AbbVie Main Business Overview
13.8.5 AbbVie Latest Developments
13.9 Johnson & Johnson
13.9.1 Johnson & Johnson Company Information
13.9.2 Johnson & Johnson Targeting DNA Repair Drugs Product Portfolios and Specifications
13.9.3 Johnson & Johnson Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Johnson & Johnson Main Business Overview
13.9.5 Johnson & Johnson Latest Developments
13.10 Pfizer
13.10.1 Pfizer Company Information
13.10.2 Pfizer Targeting DNA Repair Drugs Product Portfolios and Specifications
13.10.3 Pfizer Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Pfizer Main Business Overview
13.10.5 Pfizer Latest Developments
13.11 ClovisOncology
13.11.1 ClovisOncology Company Information
13.11.2 ClovisOncology Targeting DNA Repair Drugs Product Portfolios and Specifications
13.11.3 ClovisOncology Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 ClovisOncology Main Business Overview
13.11.5 ClovisOncology Latest Developments
13.12 GlaxoSmithKline
13.12.1 GlaxoSmithKline Company Information
13.12.2 GlaxoSmithKline Targeting DNA Repair Drugs Product Portfolios and Specifications
13.12.3 GlaxoSmithKline Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 GlaxoSmithKline Main Business Overview
13.12.5 GlaxoSmithKline Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeting DNA Repair Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Targeting DNA Repair Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Targeting DNA Repair Drugs by Country/Region, 2021, 2025 & 2032
2.2 Targeting DNA Repair Drugs Segment by Type
2.2.1 Olaparib
2.2.2 Rucaparib
2.2.3 Niraparib
2.2.4 Talazoparib
2.2.5 Others
2.2.6 Targeting DNA Repair Drugs Sales by Type
2.2.6.1 Global Targeting DNA Repair Drugs Sales Market Share by Type (2021-2026)
2.2.6.2 Global Targeting DNA Repair Drugs Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Targeting DNA Repair Drugs Sale Price by Type (2021-2026)
2.3 Targeting DNA Repair Drugs Segment by Application
2.3.1 Ovarian Cancer
2.3.2 Fallopian Tube Cancer
2.3.3 Peritoneal Cancer
2.3.4 Breast Cancer
2.3.5 Others
2.3.6 Targeting DNA Repair Drugs Sales by Application
2.3.6.1 Global Targeting DNA Repair Drugs Sale Market Share by Application (2021-2026)
2.3.6.2 Global Targeting DNA Repair Drugs Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Targeting DNA Repair Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Targeting DNA Repair Drugs Breakdown Data by Company
3.1.1 Global Targeting DNA Repair Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Targeting DNA Repair Drugs Sales Market Share by Company (2021-2026)
3.2 Global Targeting DNA Repair Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Targeting DNA Repair Drugs Revenue by Company (2021-2026)
3.2.2 Global Targeting DNA Repair Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Targeting DNA Repair Drugs Sale Price by Company
3.4 Key Manufacturers Targeting DNA Repair Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Targeting DNA Repair Drugs Product Location Distribution
3.4.2 Players Targeting DNA Repair Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TARGETING DNA REPAIR DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Targeting DNA Repair Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Targeting DNA Repair Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Targeting DNA Repair Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Targeting DNA Repair Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Targeting DNA Repair Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Targeting DNA Repair Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Targeting DNA Repair Drugs Sales Growth
4.4 APAC Targeting DNA Repair Drugs Sales Growth
4.5 Europe Targeting DNA Repair Drugs Sales Growth
4.6 Middle East & Africa Targeting DNA Repair Drugs Sales Growth
5 AMERICAS
5.1 Americas Targeting DNA Repair Drugs Sales by Country
5.1.1 Americas Targeting DNA Repair Drugs Sales by Country (2021-2026)
5.1.2 Americas Targeting DNA Repair Drugs Revenue by Country (2021-2026)
5.2 Americas Targeting DNA Repair Drugs Sales by Type (2021-2026)
5.3 Americas Targeting DNA Repair Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeting DNA Repair Drugs Sales by Region
6.1.1 APAC Targeting DNA Repair Drugs Sales by Region (2021-2026)
6.1.2 APAC Targeting DNA Repair Drugs Revenue by Region (2021-2026)
6.2 APAC Targeting DNA Repair Drugs Sales by Type (2021-2026)
6.3 APAC Targeting DNA Repair Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Targeting DNA Repair Drugs by Country
7.1.1 Europe Targeting DNA Repair Drugs Sales by Country (2021-2026)
7.1.2 Europe Targeting DNA Repair Drugs Revenue by Country (2021-2026)
7.2 Europe Targeting DNA Repair Drugs Sales by Type (2021-2026)
7.3 Europe Targeting DNA Repair Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeting DNA Repair Drugs by Country
8.1.1 Middle East & Africa Targeting DNA Repair Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Targeting DNA Repair Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Targeting DNA Repair Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Targeting DNA Repair Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Targeting DNA Repair Drugs
10.3 Manufacturing Process Analysis of Targeting DNA Repair Drugs
10.4 Industry Chain Structure of Targeting DNA Repair Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Targeting DNA Repair Drugs Distributors
11.3 Targeting DNA Repair Drugs Customer
12 WORLD FORECAST REVIEW FOR TARGETING DNA REPAIR DRUGS BY GEOGRAPHIC REGION
12.1 Global Targeting DNA Repair Drugs Market Size Forecast by Region
12.1.1 Global Targeting DNA Repair Drugs Forecast by Region (2027-2032)
12.1.2 Global Targeting DNA Repair Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Targeting DNA Repair Drugs Forecast by Type (2027-2032)
12.7 Global Targeting DNA Repair Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Onxeo
13.1.1 Onxeo Company Information
13.1.2 Onxeo Targeting DNA Repair Drugs Product Portfolios and Specifications
13.1.3 Onxeo Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Onxeo Main Business Overview
13.1.5 Onxeo Latest Developments
13.2 FoRx Therapeutics
13.2.1 FoRx Therapeutics Company Information
13.2.2 FoRx Therapeutics Targeting DNA Repair Drugs Product Portfolios and Specifications
13.2.3 FoRx Therapeutics Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 FoRx Therapeutics Main Business Overview
13.2.5 FoRx Therapeutics Latest Developments
13.3 Artios Pharma Limited
13.3.1 Artios Pharma Limited Company Information
13.3.2 Artios Pharma Limited Targeting DNA Repair Drugs Product Portfolios and Specifications
13.3.3 Artios Pharma Limited Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Artios Pharma Limited Main Business Overview
13.3.5 Artios Pharma Limited Latest Developments
13.4 Merck KGaA
13.4.1 Merck KGaA Company Information
13.4.2 Merck KGaA Targeting DNA Repair Drugs Product Portfolios and Specifications
13.4.3 Merck KGaA Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck KGaA Main Business Overview
13.4.5 Merck KGaA Latest Developments
13.5 Breakpoint Therapeutics
13.5.1 Breakpoint Therapeutics Company Information
13.5.2 Breakpoint Therapeutics Targeting DNA Repair Drugs Product Portfolios and Specifications
13.5.3 Breakpoint Therapeutics Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Breakpoint Therapeutics Main Business Overview
13.5.5 Breakpoint Therapeutics Latest Developments
13.6 Luciole Pharmaceuticals
13.6.1 Luciole Pharmaceuticals Company Information
13.6.2 Luciole Pharmaceuticals Targeting DNA Repair Drugs Product Portfolios and Specifications
13.6.3 Luciole Pharmaceuticals Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Luciole Pharmaceuticals Main Business Overview
13.6.5 Luciole Pharmaceuticals Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Targeting DNA Repair Drugs Product Portfolios and Specifications
13.7.3 AstraZeneca Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 AbbVie
13.8.1 AbbVie Company Information
13.8.2 AbbVie Targeting DNA Repair Drugs Product Portfolios and Specifications
13.8.3 AbbVie Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 AbbVie Main Business Overview
13.8.5 AbbVie Latest Developments
13.9 Johnson & Johnson
13.9.1 Johnson & Johnson Company Information
13.9.2 Johnson & Johnson Targeting DNA Repair Drugs Product Portfolios and Specifications
13.9.3 Johnson & Johnson Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Johnson & Johnson Main Business Overview
13.9.5 Johnson & Johnson Latest Developments
13.10 Pfizer
13.10.1 Pfizer Company Information
13.10.2 Pfizer Targeting DNA Repair Drugs Product Portfolios and Specifications
13.10.3 Pfizer Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Pfizer Main Business Overview
13.10.5 Pfizer Latest Developments
13.11 ClovisOncology
13.11.1 ClovisOncology Company Information
13.11.2 ClovisOncology Targeting DNA Repair Drugs Product Portfolios and Specifications
13.11.3 ClovisOncology Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 ClovisOncology Main Business Overview
13.11.5 ClovisOncology Latest Developments
13.12 GlaxoSmithKline
13.12.1 GlaxoSmithKline Company Information
13.12.2 GlaxoSmithKline Targeting DNA Repair Drugs Product Portfolios and Specifications
13.12.3 GlaxoSmithKline Targeting DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 GlaxoSmithKline Main Business Overview
13.12.5 GlaxoSmithKline Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Targeting DNA Repair Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Targeting DNA Repair Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Olaparib
Table 4. Major Players of Rucaparib
Table 5. Major Players of Niraparib
Table 6. Major Players of Talazoparib
Table 7. Major Players of Others
Table 8. Global Targeting DNA Repair Drugs Sales by Type (2021-2026) & (K Units)
Table 9. Global Targeting DNA Repair Drugs Sales Market Share by Type (2021-2026)
Table 10. Global Targeting DNA Repair Drugs Revenue by Type (2021-2026) & ($ million)
Table 11. Global Targeting DNA Repair Drugs Revenue Market Share by Type (2021-2026)
Table 12. Global Targeting DNA Repair Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Targeting DNA Repair Drugs Sale by Application (2021-2026) & (K Units)
Table 14. Global Targeting DNA Repair Drugs Sale Market Share by Application (2021-2026)
Table 15. Global Targeting DNA Repair Drugs Revenue by Application (2021-2026) & ($ million)
Table 16. Global Targeting DNA Repair Drugs Revenue Market Share by Application (2021-2026)
Table 17. Global Targeting DNA Repair Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Targeting DNA Repair Drugs Sales by Company (2021-2026) & (K Units)
Table 19. Global Targeting DNA Repair Drugs Sales Market Share by Company (2021-2026)
Table 20. Global Targeting DNA Repair Drugs Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Targeting DNA Repair Drugs Revenue Market Share by Company (2021-2026)
Table 22. Global Targeting DNA Repair Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Targeting DNA Repair Drugs Producing Area Distribution and Sales Area
Table 24. Players Targeting DNA Repair Drugs Products Offered
Table 25. Targeting DNA Repair Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Targeting DNA Repair Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Targeting DNA Repair Drugs Sales Market Share Geographic Region (2021-2026)
Table 30. Global Targeting DNA Repair Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Targeting DNA Repair Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Targeting DNA Repair Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Targeting DNA Repair Drugs Sales Market Share by Country/Region (2021-2026)
Table 34. Global Targeting DNA Repair Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Targeting DNA Repair Drugs Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Targeting DNA Repair Drugs Sales by Country (2021-2026) & (K Units)
Table 37. Americas Targeting DNA Repair Drugs Sales Market Share by Country (2021-2026)
Table 38. Americas Targeting DNA Repair Drugs Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Targeting DNA Repair Drugs Sales by Type (2021-2026) & (K Units)
Table 40. Americas Targeting DNA Repair Drugs Sales by Application (2021-2026) & (K Units)
Table 41. APAC Targeting DNA Repair Drugs Sales by Region (2021-2026) & (K Units)
Table 42. APAC Targeting DNA Repair Drugs Sales Market Share by Region (2021-2026)
Table 43. APAC Targeting DNA Repair Drugs Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Targeting DNA Repair Drugs Sales by Type (2021-2026) & (K Units)
Table 45. APAC Targeting DNA Repair Drugs Sales by Application (2021-2026) & (K Units)
Table 46. Europe Targeting DNA Repair Drugs Sales by Country (2021-2026) & (K Units)
Table 47. Europe Targeting DNA Repair Drugs Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Targeting DNA Repair Drugs Sales by Type (2021-2026) & (K Units)
Table 49. Europe Targeting DNA Repair Drugs Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Targeting DNA Repair Drugs Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Targeting DNA Repair Drugs Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Targeting DNA Repair Drugs Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Targeting DNA Repair Drugs Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Targeting DNA Repair Drugs
Table 55. Key Market Challenges & Risks of Targeting DNA Repair Drugs
Table 56. Key Industry Trends of Targeting DNA Repair Drugs
Table 57. Targeting DNA Repair Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Targeting DNA Repair Drugs Distributors List
Table 60. Targeting DNA Repair Drugs Customer List
Table 61. Global Targeting DNA Repair Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Targeting DNA Repair Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Targeting DNA Repair Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Targeting DNA Repair Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Targeting DNA Repair Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Targeting DNA Repair Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Targeting DNA Repair Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Targeting DNA Repair Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Targeting DNA Repair Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Targeting DNA Repair Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Targeting DNA Repair Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Targeting DNA Repair Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Targeting DNA Repair Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Targeting DNA Repair Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Onxeo Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Onxeo Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 77. Onxeo Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Onxeo Main Business
Table 79. Onxeo Latest Developments
Table 80. FoRx Therapeutics Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. FoRx Therapeutics Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 82. FoRx Therapeutics Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. FoRx Therapeutics Main Business
Table 84. FoRx Therapeutics Latest Developments
Table 85. Artios Pharma Limited Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Artios Pharma Limited Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 87. Artios Pharma Limited Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Artios Pharma Limited Main Business
Table 89. Artios Pharma Limited Latest Developments
Table 90. Merck KGaA Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck KGaA Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 92. Merck KGaA Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Merck KGaA Main Business
Table 94. Merck KGaA Latest Developments
Table 95. Breakpoint Therapeutics Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Breakpoint Therapeutics Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 97. Breakpoint Therapeutics Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Breakpoint Therapeutics Main Business
Table 99. Breakpoint Therapeutics Latest Developments
Table 100. Luciole Pharmaceuticals Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Luciole Pharmaceuticals Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 102. Luciole Pharmaceuticals Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Luciole Pharmaceuticals Main Business
Table 104. Luciole Pharmaceuticals Latest Developments
Table 105. AstraZeneca Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. AstraZeneca Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 107. AstraZeneca Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. AstraZeneca Main Business
Table 109. AstraZeneca Latest Developments
Table 110. AbbVie Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. AbbVie Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 112. AbbVie Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. AbbVie Main Business
Table 114. AbbVie Latest Developments
Table 115. Johnson & Johnson Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Johnson & Johnson Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 117. Johnson & Johnson Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Johnson & Johnson Main Business
Table 119. Johnson & Johnson Latest Developments
Table 120. Pfizer Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Pfizer Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 122. Pfizer Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Pfizer Main Business
Table 124. Pfizer Latest Developments
Table 125. ClovisOncology Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. ClovisOncology Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 127. ClovisOncology Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. ClovisOncology Main Business
Table 129. ClovisOncology Latest Developments
Table 130. GlaxoSmithKline Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. GlaxoSmithKline Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 132. GlaxoSmithKline Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. GlaxoSmithKline Main Business
Table 134. GlaxoSmithKline Latest Developments
Table 1. Targeting DNA Repair Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Targeting DNA Repair Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Olaparib
Table 4. Major Players of Rucaparib
Table 5. Major Players of Niraparib
Table 6. Major Players of Talazoparib
Table 7. Major Players of Others
Table 8. Global Targeting DNA Repair Drugs Sales by Type (2021-2026) & (K Units)
Table 9. Global Targeting DNA Repair Drugs Sales Market Share by Type (2021-2026)
Table 10. Global Targeting DNA Repair Drugs Revenue by Type (2021-2026) & ($ million)
Table 11. Global Targeting DNA Repair Drugs Revenue Market Share by Type (2021-2026)
Table 12. Global Targeting DNA Repair Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Targeting DNA Repair Drugs Sale by Application (2021-2026) & (K Units)
Table 14. Global Targeting DNA Repair Drugs Sale Market Share by Application (2021-2026)
Table 15. Global Targeting DNA Repair Drugs Revenue by Application (2021-2026) & ($ million)
Table 16. Global Targeting DNA Repair Drugs Revenue Market Share by Application (2021-2026)
Table 17. Global Targeting DNA Repair Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Targeting DNA Repair Drugs Sales by Company (2021-2026) & (K Units)
Table 19. Global Targeting DNA Repair Drugs Sales Market Share by Company (2021-2026)
Table 20. Global Targeting DNA Repair Drugs Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Targeting DNA Repair Drugs Revenue Market Share by Company (2021-2026)
Table 22. Global Targeting DNA Repair Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Targeting DNA Repair Drugs Producing Area Distribution and Sales Area
Table 24. Players Targeting DNA Repair Drugs Products Offered
Table 25. Targeting DNA Repair Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Targeting DNA Repair Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Targeting DNA Repair Drugs Sales Market Share Geographic Region (2021-2026)
Table 30. Global Targeting DNA Repair Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Targeting DNA Repair Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Targeting DNA Repair Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Targeting DNA Repair Drugs Sales Market Share by Country/Region (2021-2026)
Table 34. Global Targeting DNA Repair Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Targeting DNA Repair Drugs Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Targeting DNA Repair Drugs Sales by Country (2021-2026) & (K Units)
Table 37. Americas Targeting DNA Repair Drugs Sales Market Share by Country (2021-2026)
Table 38. Americas Targeting DNA Repair Drugs Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Targeting DNA Repair Drugs Sales by Type (2021-2026) & (K Units)
Table 40. Americas Targeting DNA Repair Drugs Sales by Application (2021-2026) & (K Units)
Table 41. APAC Targeting DNA Repair Drugs Sales by Region (2021-2026) & (K Units)
Table 42. APAC Targeting DNA Repair Drugs Sales Market Share by Region (2021-2026)
Table 43. APAC Targeting DNA Repair Drugs Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Targeting DNA Repair Drugs Sales by Type (2021-2026) & (K Units)
Table 45. APAC Targeting DNA Repair Drugs Sales by Application (2021-2026) & (K Units)
Table 46. Europe Targeting DNA Repair Drugs Sales by Country (2021-2026) & (K Units)
Table 47. Europe Targeting DNA Repair Drugs Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Targeting DNA Repair Drugs Sales by Type (2021-2026) & (K Units)
Table 49. Europe Targeting DNA Repair Drugs Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Targeting DNA Repair Drugs Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Targeting DNA Repair Drugs Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Targeting DNA Repair Drugs Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Targeting DNA Repair Drugs Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Targeting DNA Repair Drugs
Table 55. Key Market Challenges & Risks of Targeting DNA Repair Drugs
Table 56. Key Industry Trends of Targeting DNA Repair Drugs
Table 57. Targeting DNA Repair Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Targeting DNA Repair Drugs Distributors List
Table 60. Targeting DNA Repair Drugs Customer List
Table 61. Global Targeting DNA Repair Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Targeting DNA Repair Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Targeting DNA Repair Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Targeting DNA Repair Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Targeting DNA Repair Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Targeting DNA Repair Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Targeting DNA Repair Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Targeting DNA Repair Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Targeting DNA Repair Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Targeting DNA Repair Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Targeting DNA Repair Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Targeting DNA Repair Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Targeting DNA Repair Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Targeting DNA Repair Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Onxeo Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Onxeo Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 77. Onxeo Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Onxeo Main Business
Table 79. Onxeo Latest Developments
Table 80. FoRx Therapeutics Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. FoRx Therapeutics Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 82. FoRx Therapeutics Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. FoRx Therapeutics Main Business
Table 84. FoRx Therapeutics Latest Developments
Table 85. Artios Pharma Limited Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Artios Pharma Limited Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 87. Artios Pharma Limited Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Artios Pharma Limited Main Business
Table 89. Artios Pharma Limited Latest Developments
Table 90. Merck KGaA Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck KGaA Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 92. Merck KGaA Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Merck KGaA Main Business
Table 94. Merck KGaA Latest Developments
Table 95. Breakpoint Therapeutics Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Breakpoint Therapeutics Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 97. Breakpoint Therapeutics Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Breakpoint Therapeutics Main Business
Table 99. Breakpoint Therapeutics Latest Developments
Table 100. Luciole Pharmaceuticals Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Luciole Pharmaceuticals Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 102. Luciole Pharmaceuticals Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Luciole Pharmaceuticals Main Business
Table 104. Luciole Pharmaceuticals Latest Developments
Table 105. AstraZeneca Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. AstraZeneca Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 107. AstraZeneca Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. AstraZeneca Main Business
Table 109. AstraZeneca Latest Developments
Table 110. AbbVie Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. AbbVie Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 112. AbbVie Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. AbbVie Main Business
Table 114. AbbVie Latest Developments
Table 115. Johnson & Johnson Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Johnson & Johnson Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 117. Johnson & Johnson Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Johnson & Johnson Main Business
Table 119. Johnson & Johnson Latest Developments
Table 120. Pfizer Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Pfizer Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 122. Pfizer Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Pfizer Main Business
Table 124. Pfizer Latest Developments
Table 125. ClovisOncology Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. ClovisOncology Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 127. ClovisOncology Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. ClovisOncology Main Business
Table 129. ClovisOncology Latest Developments
Table 130. GlaxoSmithKline Basic Information, Targeting DNA Repair Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. GlaxoSmithKline Targeting DNA Repair Drugs Product Portfolios and Specifications
Table 132. GlaxoSmithKline Targeting DNA Repair Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. GlaxoSmithKline Main Business
Table 134. GlaxoSmithKline Latest Developments
LIST OF FIGURES
Figure 1. Picture of Targeting DNA Repair Drugs
Figure 2. Targeting DNA Repair Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Targeting DNA Repair Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Targeting DNA Repair Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Targeting DNA Repair Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Targeting DNA Repair Drugs Sales Market Share by Country/Region (2025)
Figure 10. Targeting DNA Repair Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Olaparib
Figure 12. Product Picture of Rucaparib
Figure 13. Product Picture of Niraparib
Figure 14. Product Picture of Talazoparib
Figure 15. Product Picture of Others
Figure 16. Global Targeting DNA Repair Drugs Sales Market Share by Type in 2026
Figure 17. Global Targeting DNA Repair Drugs Revenue Market Share by Type (2021-2026)
Figure 18. Targeting DNA Repair Drugs Consumed in Ovarian Cancer
Figure 19. Global Targeting DNA Repair Drugs Market: Ovarian Cancer (2021-2026) & (K Units)
Figure 20. Targeting DNA Repair Drugs Consumed in Fallopian Tube Cancer
Figure 21. Global Targeting DNA Repair Drugs Market: Fallopian Tube Cancer (2021-2026) & (K Units)
Figure 22. Targeting DNA Repair Drugs Consumed in Peritoneal Cancer
Figure 23. Global Targeting DNA Repair Drugs Market: Peritoneal Cancer (2021-2026) & (K Units)
Figure 24. Targeting DNA Repair Drugs Consumed in Breast Cancer
Figure 25. Global Targeting DNA Repair Drugs Market: Breast Cancer (2021-2026) & (K Units)
Figure 26. Targeting DNA Repair Drugs Consumed in Others
Figure 27. Global Targeting DNA Repair Drugs Market: Others (2021-2026) & (K Units)
Figure 28. Global Targeting DNA Repair Drugs Sale Market Share by Application (2025)
Figure 29. Global Targeting DNA Repair Drugs Revenue Market Share by Application in 2026
Figure 30. Targeting DNA Repair Drugs Sales by Company in 2026 (K Units)
Figure 31. Global Targeting DNA Repair Drugs Sales Market Share by Company in 2026
Figure 32. Targeting DNA Repair Drugs Revenue by Company in 2026 ($ millions)
Figure 33. Global Targeting DNA Repair Drugs Revenue Market Share by Company in 2026
Figure 34. Global Targeting DNA Repair Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Targeting DNA Repair Drugs Revenue Market Share by Geographic Region in 2026
Figure 36. Americas Targeting DNA Repair Drugs Sales 2021-2026 (K Units)
Figure 37. Americas Targeting DNA Repair Drugs Revenue 2021-2026 ($ millions)
Figure 38. APAC Targeting DNA Repair Drugs Sales 2021-2026 (K Units)
Figure 39. APAC Targeting DNA Repair Drugs Revenue 2021-2026 ($ millions)
Figure 40. Europe Targeting DNA Repair Drugs Sales 2021-2026 (K Units)
Figure 41. Europe Targeting DNA Repair Drugs Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Targeting DNA Repair Drugs Sales 2021-2026 (K Units)
Figure 43. Middle East & Africa Targeting DNA Repair Drugs Revenue 2021-2026 ($ millions)
Figure 44. Americas Targeting DNA Repair Drugs Sales Market Share by Country in 2026
Figure 45. Americas Targeting DNA Repair Drugs Revenue Market Share by Country (2021-2026)
Figure 46. Americas Targeting DNA Repair Drugs Sales Market Share by Type (2021-2026)
Figure 47. Americas Targeting DNA Repair Drugs Sales Market Share by Application (2021-2026)
Figure 48. United States Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Targeting DNA Repair Drugs Sales Market Share by Region in 2026
Figure 53. APAC Targeting DNA Repair Drugs Revenue Market Share by Region (2021-2026)
Figure 54. APAC Targeting DNA Repair Drugs Sales Market Share by Type (2021-2026)
Figure 55. APAC Targeting DNA Repair Drugs Sales Market Share by Application (2021-2026)
Figure 56. China Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. India Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Targeting DNA Repair Drugs Sales Market Share by Country in 2026
Figure 64. Europe Targeting DNA Repair Drugs Revenue Market Share by Country (2021-2026)
Figure 65. Europe Targeting DNA Repair Drugs Sales Market Share by Type (2021-2026)
Figure 66. Europe Targeting DNA Repair Drugs Sales Market Share by Application (2021-2026)
Figure 67. Germany Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. France Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Targeting DNA Repair Drugs Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Targeting DNA Repair Drugs Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Targeting DNA Repair Drugs Sales Market Share by Application (2021-2026)
Figure 75. Egypt Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Targeting DNA Repair Drugs in 2026
Figure 81. Manufacturing Process Analysis of Targeting DNA Repair Drugs
Figure 82. Industry Chain Structure of Targeting DNA Repair Drugs
Figure 83. Channels of Distribution
Figure 84. Global Targeting DNA Repair Drugs Sales Market Forecast by Region (2027-2032)
Figure 85. Global Targeting DNA Repair Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Targeting DNA Repair Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Targeting DNA Repair Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Targeting DNA Repair Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Targeting DNA Repair Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Targeting DNA Repair Drugs
Figure 2. Targeting DNA Repair Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Targeting DNA Repair Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Targeting DNA Repair Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Targeting DNA Repair Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Targeting DNA Repair Drugs Sales Market Share by Country/Region (2025)
Figure 10. Targeting DNA Repair Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Olaparib
Figure 12. Product Picture of Rucaparib
Figure 13. Product Picture of Niraparib
Figure 14. Product Picture of Talazoparib
Figure 15. Product Picture of Others
Figure 16. Global Targeting DNA Repair Drugs Sales Market Share by Type in 2026
Figure 17. Global Targeting DNA Repair Drugs Revenue Market Share by Type (2021-2026)
Figure 18. Targeting DNA Repair Drugs Consumed in Ovarian Cancer
Figure 19. Global Targeting DNA Repair Drugs Market: Ovarian Cancer (2021-2026) & (K Units)
Figure 20. Targeting DNA Repair Drugs Consumed in Fallopian Tube Cancer
Figure 21. Global Targeting DNA Repair Drugs Market: Fallopian Tube Cancer (2021-2026) & (K Units)
Figure 22. Targeting DNA Repair Drugs Consumed in Peritoneal Cancer
Figure 23. Global Targeting DNA Repair Drugs Market: Peritoneal Cancer (2021-2026) & (K Units)
Figure 24. Targeting DNA Repair Drugs Consumed in Breast Cancer
Figure 25. Global Targeting DNA Repair Drugs Market: Breast Cancer (2021-2026) & (K Units)
Figure 26. Targeting DNA Repair Drugs Consumed in Others
Figure 27. Global Targeting DNA Repair Drugs Market: Others (2021-2026) & (K Units)
Figure 28. Global Targeting DNA Repair Drugs Sale Market Share by Application (2025)
Figure 29. Global Targeting DNA Repair Drugs Revenue Market Share by Application in 2026
Figure 30. Targeting DNA Repair Drugs Sales by Company in 2026 (K Units)
Figure 31. Global Targeting DNA Repair Drugs Sales Market Share by Company in 2026
Figure 32. Targeting DNA Repair Drugs Revenue by Company in 2026 ($ millions)
Figure 33. Global Targeting DNA Repair Drugs Revenue Market Share by Company in 2026
Figure 34. Global Targeting DNA Repair Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Targeting DNA Repair Drugs Revenue Market Share by Geographic Region in 2026
Figure 36. Americas Targeting DNA Repair Drugs Sales 2021-2026 (K Units)
Figure 37. Americas Targeting DNA Repair Drugs Revenue 2021-2026 ($ millions)
Figure 38. APAC Targeting DNA Repair Drugs Sales 2021-2026 (K Units)
Figure 39. APAC Targeting DNA Repair Drugs Revenue 2021-2026 ($ millions)
Figure 40. Europe Targeting DNA Repair Drugs Sales 2021-2026 (K Units)
Figure 41. Europe Targeting DNA Repair Drugs Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Targeting DNA Repair Drugs Sales 2021-2026 (K Units)
Figure 43. Middle East & Africa Targeting DNA Repair Drugs Revenue 2021-2026 ($ millions)
Figure 44. Americas Targeting DNA Repair Drugs Sales Market Share by Country in 2026
Figure 45. Americas Targeting DNA Repair Drugs Revenue Market Share by Country (2021-2026)
Figure 46. Americas Targeting DNA Repair Drugs Sales Market Share by Type (2021-2026)
Figure 47. Americas Targeting DNA Repair Drugs Sales Market Share by Application (2021-2026)
Figure 48. United States Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Targeting DNA Repair Drugs Sales Market Share by Region in 2026
Figure 53. APAC Targeting DNA Repair Drugs Revenue Market Share by Region (2021-2026)
Figure 54. APAC Targeting DNA Repair Drugs Sales Market Share by Type (2021-2026)
Figure 55. APAC Targeting DNA Repair Drugs Sales Market Share by Application (2021-2026)
Figure 56. China Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. India Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Targeting DNA Repair Drugs Sales Market Share by Country in 2026
Figure 64. Europe Targeting DNA Repair Drugs Revenue Market Share by Country (2021-2026)
Figure 65. Europe Targeting DNA Repair Drugs Sales Market Share by Type (2021-2026)
Figure 66. Europe Targeting DNA Repair Drugs Sales Market Share by Application (2021-2026)
Figure 67. Germany Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. France Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Targeting DNA Repair Drugs Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Targeting DNA Repair Drugs Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Targeting DNA Repair Drugs Sales Market Share by Application (2021-2026)
Figure 75. Egypt Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Targeting DNA Repair Drugs Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Targeting DNA Repair Drugs in 2026
Figure 81. Manufacturing Process Analysis of Targeting DNA Repair Drugs
Figure 82. Industry Chain Structure of Targeting DNA Repair Drugs
Figure 83. Channels of Distribution
Figure 84. Global Targeting DNA Repair Drugs Sales Market Forecast by Region (2027-2032)
Figure 85. Global Targeting DNA Repair Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Targeting DNA Repair Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Targeting DNA Repair Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Targeting DNA Repair Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Targeting DNA Repair Drugs Revenue Market Share Forecast by Application (2027-2032)
